Sections

Home
I Am About To Start
Resources for Current Staff
Other links and resources
Recent posters & publications
Guidelines

You are here: Home → Resources for Current Staff → Microbiology and Antimicrobial Pharmacology → COVID-19 → Background and detailed articles - in reverse date order → A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Site Map
Accessibility
Editor Log in

Skip to content. | Skip to navigation

Navigation

Background and detailed articles - in reverse date order
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Geographic and Genomic Distribution of SARS-CoV-2 Mutations
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Association between high serum total cortisol concentrations and mortality from COVID-19
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
COVID Testing FAQ, From Reinfection to Persistent Positives
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
Postmortem Examination of Patients With COVID-19
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
The immunology of COVID-19: is immune modulation an option for treatment?
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
The Science Underlying COVID-19: Implications for the Cardiovascular System
The immunology of ARDS due to SARS, MERS & H7N9
Phylogenetic network analysis of SARS-CoV-2 genomes
C19 receptor stucture and functional biology - Nature March2020
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
On the origin and continuingevolution of SARS-CoV-2
The Korean clusters
WUHAN CORONAVIRUS Genetics of the new virus
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Search: Advanced Search…

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

The link address is: https://www.nejm.org/doi/full/10.1056/NEJMoa2001282?query=featured_home

Document Actions

Send this
Print this